Commercial development of stem cell technology: lessons from the past, strategies for the future. (November 2006)

• Record Type: Journal Article
• Authors: Martin, Paul A; Coveney, Catherine; Kraft, Alison; Brown, Nik; Bath, Philip
• Is Part Of: Regenerative medicine. Volume 1:Number 6(2006)
• Page Start: 801
• Page End: 807
• Publication Date: 2006-11
• Subjects: firm strategies -- industry -- public policy -- stem cells; Cellular therapy -- Periodicals; Stem cells -- Transplantation -- Periodicals; Degeneration (Pathology) -- Treatment -- Periodicals; Regeneration (Biology) -- Periodicals; 611.018
• DOI: 10.2217/17460751.1.6.801
• Languages: English
• ISSNs: 1746-0751

Abstract

This paper presents historical and contemporary survey data on the commercial development of stem cell technology from the 1990s to the present day. We describe the first wave of industrial investment in hematopoietic stem cells during the 1990s and contrast this with the more recent expansion of the sector. In particular, we explore the cell types used, diseases targeted and business models adopted by firms. We conclude, by arguing that the commercial prospects for stem cell technologies remain highly uncertain and that innovative public policies should be adopted to prevent ''market failure''.